MX9202243A - Composicion farmaceutica de antagonista del receptor de angiotensina ii y bloqueadores del canal de calcio. - Google Patents
Composicion farmaceutica de antagonista del receptor de angiotensina ii y bloqueadores del canal de calcio.Info
- Publication number
- MX9202243A MX9202243A MX9202243A MX9202243A MX9202243A MX 9202243 A MX9202243 A MX 9202243A MX 9202243 A MX9202243 A MX 9202243A MX 9202243 A MX9202243 A MX 9202243A MX 9202243 A MX9202243 A MX 9202243A
- Authority
- MX
- Mexico
- Prior art keywords
- angiotensin
- pharmaceutical composition
- receptor antagonist
- calcium channel
- channel blockers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70074091A | 1991-05-15 | 1991-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9202243A true MX9202243A (es) | 1992-11-01 |
Family
ID=24814683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9202243A MX9202243A (es) | 1991-05-15 | 1992-05-14 | Composicion farmaceutica de antagonista del receptor de angiotensina ii y bloqueadores del canal de calcio. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0584250A1 (es) |
| JP (1) | JP2930252B2 (es) |
| AU (1) | AU664375B2 (es) |
| CA (1) | CA2103276A1 (es) |
| CZ (1) | CZ281570B6 (es) |
| IE (1) | IE921534A1 (es) |
| IL (1) | IL101858A (es) |
| MX (1) | MX9202243A (es) |
| NZ (1) | NZ242724A (es) |
| WO (1) | WO1992020342A1 (es) |
| ZA (1) | ZA923557B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3057471B2 (ja) | 1993-06-07 | 2000-06-26 | 武田薬品工業株式会社 | アンジオテンシンｉｉ介在性諸疾患の予防または治療剤 |
| AU696868B2 (en) * | 1994-03-29 | 1998-09-17 | Merck & Co., Inc. | Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles |
| PT804229E (pt) | 1995-03-16 | 2003-06-30 | Pfizer | Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica |
| US6204281B1 (en) | 1998-07-10 | 2001-03-20 | Novartis Ag | Method of treatment and pharmaceutical composition |
| ID27664A (id) | 1998-07-10 | 2001-04-19 | Novartis Ag | Kombinasi antihipersensitif dari valsartan dan penghalang saluran kalsium |
| US7481803B2 (en) * | 2000-11-28 | 2009-01-27 | Flowmedica, Inc. | Intra-aortic renal drug delivery catheter |
| US6395728B2 (en) | 1999-07-08 | 2002-05-28 | Novartis Ag | Method of treatment and pharmaceutical composition |
| TWI290470B (en) * | 1999-12-01 | 2007-12-01 | Sankyo Co | The composition for treating glaucoma |
| GB0008332D0 (en) * | 2000-04-04 | 2000-05-24 | Pfizer Ltd | Treament |
| WO2001082858A2 (de) * | 2000-05-04 | 2001-11-08 | Ipf Pharmaceuticals Gmbh | Neue verbindungen zur behandlung inflammatorischer und kardiovaskulärer erkrankungen |
| WO2002043807A2 (en) * | 2000-12-01 | 2002-06-06 | Novartis Ag | Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction |
| EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
| EP3045174A1 (en) * | 2003-01-31 | 2016-07-20 | Daiichi Sankyo Company, Limited | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| TW200833325A (en) * | 2006-12-26 | 2008-08-16 | Daiichi Sankyo Co Ltd | Pharmaceutical composition comprising ascorbic acid |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2607004B1 (fr) * | 1986-11-20 | 1990-06-01 | Synthelabo | Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine |
| US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| CA2020073A1 (en) * | 1989-07-03 | 1991-01-04 | Eric E. Allen | Substituted quinazolinones as angiotensin ii antagonists |
| KR100222252B1 (ko) * | 1990-12-14 | 1999-10-01 | 스튜어트 알. 수터 | 안지오텐신 ii 수용체 차단 조성물 |
-
1992
- 1992-05-13 NZ NZ242724A patent/NZ242724A/xx not_active IP Right Cessation
- 1992-05-14 AU AU20269/92A patent/AU664375B2/en not_active Expired
- 1992-05-14 CZ CS932351A patent/CZ281570B6/cs not_active IP Right Cessation
- 1992-05-14 MX MX9202243A patent/MX9202243A/es unknown
- 1992-05-14 JP JP5500110A patent/JP2930252B2/ja not_active Expired - Lifetime
- 1992-05-14 EP EP92912707A patent/EP0584250A1/en not_active Withdrawn
- 1992-05-14 IL IL10185892A patent/IL101858A/en not_active IP Right Cessation
- 1992-05-14 WO PCT/US1992/003873 patent/WO1992020342A1/en not_active Application Discontinuation
- 1992-05-14 CA CA002103276A patent/CA2103276A1/en not_active Abandoned
- 1992-05-15 ZA ZA923557A patent/ZA923557B/xx unknown
- 1992-07-01 IE IE153492A patent/IE921534A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU664375B2 (en) | 1995-11-16 |
| WO1992020342A1 (en) | 1992-11-26 |
| EP0584250A1 (en) | 1994-03-02 |
| IE921534A1 (en) | 1992-11-18 |
| EP0584250A4 (es) | 1994-03-30 |
| JP2930252B2 (ja) | 1999-08-03 |
| AU2026992A (en) | 1992-12-30 |
| CA2103276A1 (en) | 1992-11-16 |
| NZ242724A (en) | 1994-09-27 |
| IL101858A0 (en) | 1992-12-30 |
| JPH06508128A (ja) | 1994-09-14 |
| ZA923557B (en) | 1993-11-15 |
| CZ281570B6 (cs) | 1996-11-13 |
| IL101858A (en) | 1996-08-04 |
| CZ235193A3 (en) | 1994-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9202243A (es) | Composicion farmaceutica de antagonista del receptor de angiotensina ii y bloqueadores del canal de calcio. | |
| BR9206722A (pt) | Antagonista receptores de endotelina | |
| DE69223561D1 (de) | Verbesserter optischer Multiplexer und Demultiplexer | |
| DK0667148T3 (da) | Peroralt farmaceutisk præparat, der udløses i den nedre del af mavetarmkanalen | |
| DK0938318T3 (da) | Tablet med kontrolleret frigivelse af alfuzosinchlorhydrat | |
| NO934163D0 (no) | HER4 human reseptor-tyrosinkinase | |
| ATE397459T1 (de) | Sofort auflösbare medizinische zusammenstellung | |
| NO303524B1 (no) | Vannbasert dentalsement | |
| FI932517A0 (fi) | Antagonister av angiotensin II | |
| DE59204397D1 (de) | Hochfliessfähige Propylen-Ethylen-Copolymerisate. | |
| DE69429861D1 (de) | Endothelin-rezeptor-antagonisten | |
| DE69623255D1 (de) | Zahnzementzusammensetzung | |
| MA22288A1 (fr) | Compositions de shampooings doux | |
| FR2675372B1 (fr) | Prothese ossiculaire auto-ajustable de l'oreille moyenne. | |
| FI923497A0 (fi) | Roterande anslutning med laonglivad taetning. | |
| FI913608A0 (fi) | Doseringsform foer dosering av kalciumantagonist. | |
| IT1301451B1 (it) | Copolimeri del clorotrifluoroetilene | |
| DE69603346D1 (de) | Zusammensetzung von Propylen-Block-Copolymeren | |
| IS4597A (is) | Ný lyfjafræðileg notkun AII-viðtaka mótlyfja | |
| BR9609914A (pt) | Antagonista do receptor de endotelina | |
| DE69604968D1 (de) | Wagenblockierkeil | |
| AR002996A1 (es) | Isoxazolinas mejoradas antagonistas del receptore de fibrinogeno. | |
| DE69310150D1 (de) | Dentalzement | |
| BR9603432A (pt) | Antagonistas de receptores de endotelina | |
| LU90305B1 (de) | Zusammenziehbare Damenbinde |